RATIO-ORCIPRENALINE SYRUP 2MG/ML 2 MG
ORCIPRENALINE SULFATE : 2 MG · DIN 02152568 · RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
Health Canada status: CANCELLED POST MARKET
What is RATIO-ORCIPRENALINE SYRUP 2MG/ML?
RATIO-ORCIPRENALINE SYRUP 2MG/ML 2 MG contains ORCIPRENALINE SULFATE : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02152568, held by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED, supplied as SYRUP for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Aug-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02152568 |
|---|---|
| Brand name | RATIO-ORCIPRENALINE SYRUP 2MG/ML |
| Generic / active ingredient | ORCIPRENALINE SULFATE : 2 MG |
| Manufacturer | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED |
| Strength | 2 MG |
| Dosage form | SYRUP |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | R03CB03 ORCIPRENALINE |
| AHFS class | 12:12.08.12 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 04-Aug-2006 |
| Original market date | 1997-01-06 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code R03CB03 ORCIPRENALINE. 0 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALUPENT SYR 10MG/5.0ML | 10 MG / 5 ML | SYRUP | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | CANCELLED POST MARKET | DIN 00249920 |
| ALUPENT TAB 20MG | 20 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | CANCELLED POST MARKET | DIN 00003891 |
| ORCIPREN | 10 MG / 5 ML | SYRUP | TECHNILAB PHARMA INC. | CANCELLED POST MARKET | DIN 02229862 |
| ORCIPRENALINE | 2 MG | SYRUP | APOTEX INC | APPROVED | DIN 02236565 |
| ORCIPRENALINE | 2 MG | SYRUP | AA PHARMA INC | DORMANT | DIN 02236783 |
| TANTA ORCIPRENALINE SYRUP - SYR 2MG/ML | 2 MG | SYRUP | TANTA PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 02192675 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.